#TFDAApproval

Exciting news! Leadgene Biomedical, Inc.'s LEADGENE® Indoxyl Sulfate (IS) ELISA Kit, a CE-marked protein-bound toxin diagnosis kit, has been approved by Taiwan's FDA as a Class III in vitro diagnostic device (#IVD).

LEADGENE's Chairman, Chasel Yung-Chun Chuang (莊詠鈞), expressed optimism about the market potential of their LEADGENE® IS ELISA Kit. By obtaining #TFDA approval, the company aims to reduce Taiwan's reliance on imported biological materials, lower testing costs, and seize the golden treatment period for kidney disease patients requiring dialysis.

Read more: https://lnkd.in/gPvaYdhe

Follow #Globalbio for groundbreaking #biomedicine updates!